MergerLinks Header Logo

Announced

Completed

Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical for $100m.

Synopsis

Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical, a generic drug manufacturer, for $100m.

Principals

Nichi-iko (sagent Pharmaceuticals And Omega Laboratories)

target

Nichi-iko (sagent Pharmaceuticals And Omega Laboratories)

Elliminist Singapore

bidder

Elliminist Singapore

Show Details & Financials

Market Context

Osler Hoskin & Harcourt

legal advisors

Osler Hoskin & Harcourt

Jefferies & Company

financial advisors

Jefferies & Company

Latham & Watkins

legal advisors

Latham & Watkins

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US